GIM
LFCR icon

Granahan Investment Management’s Lifecore Biomedical LFCR Stock Holding History

Granahan Investment Management’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-54,225
Closed -$641K – 225
2015
Q4 		$641K Sell
54,225
-107,194
-66% -$1.32M 0.02% 232
2015
Q3 		$1.88M Sell
161,419
-53,806
-25% -$713K 0.06% 226
2015
Q2 		$3.11M Sell
215,225
-55,600
-21% -$802K 0.09% 199
2015
Q1 		$3.78M Sell
270,825
-90,275
-25% -$1.25M 0.11% 188
2014
Q4 		$4.99M Buy
+361,100
New +$4.67M 0.15% 163

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Granahan Investment Management's LFCR Position: Q1 2016 in Review

Granahan Investment Management sold out of Lifecore Biomedical (LFCR) in Q1 2016, closing a stake of 54,225 shares — an estimated $641K sold.

Granahan Investment Management first reported a position in LFCR in Q4 2014 and held it in 5 quarters. The position peaked at $4.99M in Q4 2014. 96 funds tracked by Wall St. Rank hold LFCR as of Q1 2016.

  • Granahan Investment Management reported no remaining Lifecore Biomedical position as of Q1 2016 after selling out during the quarter.
  • Granahan Investment Management sold 54,225 Lifecore Biomedical shares in Q1 2016, an estimated $641K.
  • Granahan Investment Management first reported a position in Lifecore Biomedical in Q4 2014 and held it in 5 quarters.
  • Granahan Investment Management's Lifecore Biomedical position peaked at $4.99M in Q4 2014.
  • 96 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2016.

Based on Granahan Investment Management's 13F filing for Q1 2016, filed 13 May 2016.